跳至主要内容
临床试验/NCT00674154
NCT00674154已完成2 期

Effect of Vitamin D Treatment in Primary Hyperparathyroidism

University of Aarhus1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2008年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
46
试验地点
1
主要终点
Decrease in Preoperative P-PTH

研究概览

简要总结

The primary aim of the study is to assess whether 6-months of vitamin D supplements can decrease PTH compared with placebo treatment in primary hyperparathyroidism.

详细描述

The study investigates effects and safety of six months of vitamin D supplementation before and after surgery in primary hyperparathyroidism. Effects are assessed as changes in calcium homeostasis, bone metabolism, quality of life, and muscle strength and function.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • P-Ca-ion > 1,30 mmol/l
  • P-PTH > 5 pmol/l
  • P-OH25-vitamin D < 80 nmol/l

排除标准

  • P-creatinin > 120 mumol/l
  • usage of Etalpha, Mimpara
  • Sarcoidosis
  • malabsorption
  • pancreatitis
  • alcohol abuse
  • pregnancy

研究组 & 干预措施

Vitamin D group

Experimental

Cholecalciferol 1400 IU, 2 tablets once daily in 52 weeks

干预措施: Cholecalciferol (Drug)

Placebo group

Placebo Comparator

Placebo, two tablets daily in 52 weeks.

干预措施: Cholecalciferol (Drug)

结局指标

主要结局

Decrease in Preoperative P-PTH

时间窗: 25 weeks

Decrease in plasma PTH after 25 weeks of preoperative vitamin D treatment compared with the plasebo Group.

次要结局

  • Increased Bone Mineral Density(One year)
  • Increase in Quality of Life(One year)
  • Improved Muscular Function(One Year)
  • Reduced Postoperative Hypocalcemia(Postoperative week)
  • Increase in Trabecular and Cortical vBMD Measured by QCT and pQCT of Hip, Spine and Forearm(one year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验